Business Description
Invivyd is a US-based biopharmaceutical company focused on developing antibody-based medicines to protect people from viral infections. Its main product, sold under the name PEMGARDA, helps prevent COVID-19 in adults and teenagers who cannot rely on vaccines alone. The company also has several treatments in development, including antibodies targeting other strains of COVID-19 and a therapy designed to shield newborns and young children from respiratory viruses. Founded in 2020 and based in New Haven, Connecticut, Invivyd works with outside partners to discover and refine its pipeline of medicines.
